Skip to main content
SpringerLink
Log in

Nicotine replacement therapies make economic sense

  • Drug Economics and Quality of Life
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. More evidence required to prove economic effectiveness of nicotine-based products. Drug Ther Perspect 1994 Feb 7; 3(2): 15–6

    Google Scholar 

  2. The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. JAMA 1996 Apr 24; 275(16): 1270–80

    Google Scholar 

  3. Jorenby DE, Keehn DS, Fiore MC. Comparative efficacy and tolerability of nicotine replacement therapies. CNS Drugs 1995 Mar; 3(3): 227–36

    Article  Google Scholar 

  4. de Wit H, Zacny J. Abuse potential of nicotine replacement therapies. CNS Drugs 1995 Dec; 4(6): 456–68

    Article  CAS  Google Scholar 

  5. British National Formulary No. 31. London: The Pharmaceutical Press, 1996 Mar: 220–1

  6. 1995 Physicians GenRx. St Louis, Missouri: Mosby-Year Book, Inc., 1995: 1414–22

  7. Silagy C, Mant D, Fowler G, et al. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994 Jan 15; 343: 139–42

    Article  PubMed  CAS  Google Scholar 

  8. Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of the nicotine patch for smoking cessation. JAMA 1994 June 22/29; 271(24): 1940–479.

    Article  PubMed  CAS  Google Scholar 

  9. McGhan WF, Dix Smith M. Pharmacoeconomic analysis of smoking-cessation interventions. Am J Health Syst Pharm 1996 Jan 1; 53: 45–52

    PubMed  CAS  Google Scholar 

  10. Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians’ smoking cessation counseling. JAMA 1996 Apr 24; 275: 1247–51

    Article  PubMed  CAS  Google Scholar 

  11. Akehurst RL, Piercy J. Cost-effectiveness of the use of transdermal Nicorette patches relative to GP counselling and nicotine gum in the prevention of smoking-related diseases. Br J Med Econom 1994; 7: 115–22

    Google Scholar 

  12. Akehurst R, Piercy J. Cost-effectiveness of the use of Nicorette nasal spray to assist quitting smoking among heavy smokers. Br J Med Econom 1994; 7: 155–84

    Google Scholar 

  13. Mason P. Action on smoking — can pharmacists make a difference? Pharm J 1996 Feb 24; 256: 263–5

    Google Scholar 

  14. Davis RM. The ledger of tobacco control: is the cup half empty or half full? [editorial]. JAMA 1996 Apr 24; 275(16): 1281–4

    Article  PubMed  CAS  Google Scholar 

  15. Nicotine-based products for OTC use in the US. Inpharma 1996 May 4; (1035): 21

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nicotine replacement therapies make economic sense. Drugs Ther. Perspect 7, 13–16 (1996). https://doi.org/10.2165/00042310-199607120-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607120-00005

Keywords

Search

Navigation